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Figure S7. Shape of CH2-N=C signal of 10 (above) and of CH2-NH- signal of 6 E, Z  (under) in the 1H NMR spectra 4 
 5 
Experimental procedure S8.  6 
Synthesis of  αN-tert-butoxycarbonyl-L-arginine (2) [16a, c] 7 
In a one-neck flask, equipped with magnetic stirrer, we introduced L-arginine HCl (1.00; 4.8 mmol), dioxane (3.3 mL) 8 
and 1 N NaOH (5.0 mmol). After cooling at 0°C, Di-tert-butyl-carbonate (Boc2O) was added (1.1 equiv.) and the reaction 9 
mixture was left under stirring for one night at r.t. The progress of the reaction was followed by TLC eluted in ethyl 10 
acetate (AcOEt)/MeOH 9/1. Then the reaction mixture was poured into a separating funnel and extracted with n-hexane. 11 
The organic phase was treated with saturated NaHCO3 and the aqueous phases combined, acidified with 10% KHSO4 to 12 
pH = 2, while cooled at 0°C, extracted with tert-butanol and dried on Na2SO4 overnight. After evaporation of the solvent 13 
at reduced pressure was obtained 2 that was investigated by IR and NMR analysis for checking the degree of purity and 14 
was used in the next step without further purifications. 15 
αN-tert-butoxycarbonyl-L-arginine (2) [16a, b, c] 1.21 g, white solid, 92% yield; m.p. 150°C dec., lit. 159-160 °C dec. 16 
[16a], 145-150°C dec. [16c]; FTIR (KBr) 3500-2400 (OH), 3374 (NH), 3203 (NH), 1729 (C=O acid), 1671 (C=O 17 
urethanecarbamate) cm-1; 1H NMR (300 MHz; DMSO-d6) δ 1.38 (s, 9H, CH3 Boc), 1.49-1.69 (m, 4H, βCH2γCH2 ), 3.09 18 
(m, 2H, δCH2), 3.84 (m, 1H, αCH), 7.04 (d, J = 7.9 Hz, 1H αNH), 7.30 (brs, 3H, ωNH2 + ω’NH), 7.92 (t, 1H, δNH); 13C 19 
NMR (75.5 MHz; DMSO-d6) δ 25.45, 28.39, 31.30, 41.30, 53.42, 78.18, 155.71, 157.04, 174.29; Anal Calc. for 20 




Experimental procedure S9.  2 
Synthesis of  αN-tert-butoxycarbonyl-L-ornithine (4) [22]  3 
In a 50 mL two-neck flask  αN-tert-butoxycarbonyl-δN-Cbz-L-ornithine (2.05 g, 5.6 mmol), Pd/C 10% (1.19 g) and MeOH 4 
(38 mL) were introduced and the reaction mixture was maintained under stirring and at r.t. and under H2 pressure (1.5 5 
bar) for 5 h. After checking the completeness of the reaction by TLC (MeOH 100%), the catalyst is eliminated by filtration 6 
on a celite plug which was washed with H2O two times. The filtrate was evaporated at reduced pressure and at temperature 7 
not exceeding 50-60°C to obtain an off-white solid which was treated with tetrahydrofuran (THF) and filtered. After 8 
washing with THF the solid was brought to constant weight under reduced pressure and then left overnight in a desiccator 9 
over P2O5 obtaining the desired product. 10 
αN-tert-butoxycarbonyl-L-ornithine (4) [22b] 1.06 g, white solid, 81.6% yield; m.p. dec.; FTIR (KBr) 3500-2400 (OH), 11 
3380 (NH2), 1690 (C=O acid + C=O urethanecarbamate), 1585 (NH) cm-1; 1H NMR (300 MHz; DMSO-d6/D2O) δ 1.41 12 
(s, 9H, CH3 Boc), 1.50-1.80 (m, 4H, βCH2γCH2),  2.89 (t, J = 6.5 Hz, 2H δCH2) 3.80 (m, 1H, αCH); 13C NMR (75.5 MHz; 13 
DMSO-d6/D2O) δ 25.42, 30.25, 31.58, 40.90, 57.01, 81.83, 158.35, 178.92; Anal Calc. for C10H20N2O4 (232.28): C, 14 
51.71%; H, 8.68%; N, 12.06%; found: C, 51.47%; H, 8.94%; N, 12.28%. 15 
 16 
Experimental procedure S10. 17 
Synthesis of 1,3-Bis(tert-butoxycarbonyl)guanidine (8) [26] 18 
In a 20 mL one-neck flask guanidine hydrochloride 7 (1.19 g, 12.5 mmol), H2O (12.5 mL) and dioxane (2.5 mL) were 19 
inserted. The reaction mixture was added under stirring at 0 °C with di-tert-butyl carbonate (5.98 g, 27.4 mmol) and 20 
maintained at r.t. for 24 h, then was evaporated up to a third of the volume obtaining a white suspension which after 21 
dilution with H2O (25 mL) was extracted with AcOEt (3 x 25 mL). The extracts were washed with 10% citric acid (15 22 
mL), H2O (15 mL), saturated NaCl (15 mL) and dried over anhydrous Na2SO4 overnight. The elimination of the solvent 23 
at reduced pressure gave a solid which was treated with petroleum ether and filtered, obtaining 8.  24 
1,3-Bis(tert-butoxycarbonyl)guanidine (8) [26] 1.94 g, white solid, 60% yield; m.p. 145-147°C (petroleum ether), lit. 25 
144°C [26]; FTIR (KBr) 3370 (NH), 3310 (NH), 1588 (C=NH), 1730 (C=O), 1638 (NH) cm-1; 1H NMR (300 MHz; 26 
DMSO-d6) δ 1.41 (s, 18H, CH3 Boc), 8.00-11.00 (two brs, 3H, NH); 13C NMR (75.5 MHz; DMSO-d6) δ 28.80, 80.51, 27 






Experimental procedure S11. 1 
Synthesis of 1,3-Bis(tert-butoxycarbonyl)-2-(trifluoromethylsulfonyl)guanidine (9) [26] 2 
In a 50 ml two-neck flask equipped with a dropping funnel, magnetic stirrer and a nitrogen valve 8 (1.86 g, 7.2 mmol), 3 
CH2Cl2 (36 mL) and Et3N (1.0 mL) were inserted. After cooling at -78°C, the mixture was added dropwise with triflic 4 
anhydride (1.3 mL), the solution was allowed to reach r.t. and was stirred under nitrogen stream for 24 h. The dark solution 5 
was then washed with 2 N KHSO4 and H2O and the organic phase was dried over anhydrous Na2SO4. The elimination of 6 
the solvent under reduced pressure provided the crude 9 which was dissolved in CH2Cl2 (10 mL) and was percolated on 7 
a small silica column (h = 10 cm, ø = 2 cm) eluting with CH2Cl2 (20 mL). The elimination of the solvent under reduced 8 
pressure provided 9. 9 
1,3- Bis(tert-butoxycarbonyl)-2-(trifluoromethylsulfonyl)guanidine (9) [26] 1.98 g, white solid, 70% yield; m.p. 105-10 
108°C, lit. 115°C [26]; FTIR (KBr) 3377 (NH), 3306 (NH), 1787 (C=NSO2CF3), 1736 (C=O), 1631 (NH) cm-1; 1H NMR 11 
(300 MHz; CDCl3) δ 1.54 (s, 18H CH3 Boc), 10.1 (br s, 2H, NH); 13C NMR (75.5 MHz; CDCl3) δ 27.84, 86.02, 117.16, 12 
121.40, 151.43; Anal Calcd for C12H20F3N3O6 (391.36): C, 36.83%; H, 5.15%; N, 14.56%; Found: C, 36.77 %; H, 5.04%; 13 



































































































































































































































































Spectrum S13. 1H NMR (300 MHz, DMSO) of compound 2 5 
 6 
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Compounds 3a+3b 1 
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Compound 3a 1 
 2 
Spectrum S17. 1H NMR (300 MHz, CDCl3) of compound 3a 3 
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Compound 3c 1 
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Spectrum S22. 13C NMR  and DEPT-135 (75.5 MHz, DMSO/D2O) of compound 4 2 
 3 
Compound 6 E/Z 4 
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Spectrum S24. 13C NMR  and DEPT-135 (75.5 MHz, CDCl3) of compound 6 E, Z 3 
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Compound 10 5 
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Figure S28. 3D overlapping images of the two rotamers 6 E, Z  and of their tautomer 10 with the calculated energy 7 
associated to their structure 8 
 9 
